BioStock: Medivir signs new clinical trial collaboration with Eisai

Medivir has entered into a clinical trial collaboration and supply agreement with Eisai to evaluate its liver-targeted treatment, fostrox, in combination with lenvatinib for advanced liver cancer. This partnership allows Medivir to build on the promising results from the ongoing phase Ib/IIa study by advancing to a randomized phase IIb study.

Read the article at biostock.se:

https://www.biostock.se/en/2024/11/medivir-signs-new-clinical-trial-collaboration-with-eisai/

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/